News & Analysis on Clinical Trial Services & Contract Research And Development
Preparing for 2017
By Melissa Fassbender
- Last updated on
Moving in to the New Year, Price said CROs and CMOs need to re-evaluate their programs and service offerings to determine if they will meet current market demands today, as well as 18 to 24 months in the future.
“Projects that were a good idea a few years ago may no longer be worthwhile today or in the near future,” he explained, adding that the industry has already seen in increase in raw material price and GDUFA fees – making discovery more expensive.
“CROs and CMOs need to figure out what they need to be doing over the next five years, and making moves to address those needs,” said Price.
“That’s not different from any other period, but we do expect accelerated change – good or bad – over the next four years.”